TrialEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology2015

An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate.

Ralitza Gueorguieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.